Ulmer & Berne LLP is pleased to announce the addition of Andrew Lehmkuhl as an Associate in its Product Liability Practice Group. Lehmkuhl joins Ulmer’s Cincinnati office where he will focus on product liability litigation and the defense of pharmaceutical, biologic, medical device, dietary supplement, and mass and toxic tort claims.
“We’re very glad to have Drew join us in assisting our clients with complex product liability matters,” said Jeffrey F. Peck, Chair of Ulmer’s Product Liability Practice Group. “Drew’s scientific background and skill in understanding complex medical and other scientific issues benefits our clients and adds to the collective expertise of our growing product liability team.”
With a bachelor’s degree in neuroscience and a master’s degree in experimental psychology, Lehmkuhl uses his unique background to understand the medical and scientific issues that arise in cases in which Ulmer defends its clients. Lehmkuhl also assists with pleadings, motion practice, pretrial discovery, and trial preparation.
Prior to law school, Lehmkuhl worked as a Graduate Research Assistant for the University of Cincinnati in the areas of neuroethology and neurogenerative diseases, and for the Cincinnati Children’s Hospital in the area of human genetics. He received his bachelor’s and master’s degrees from the University of Cincinnati, and his law degree from the University of Cincinnati College of Law, where he served as Editor-in-Chief of the Law Review.
Lehmkuhl joins Ulmer’s robust team of product liability litigators who are nationally recognized for successfully managing matters that are complex, both legally and scientifically, and for their unique and comprehensive approach to addressing clients’ needs. Serving numerous companies in the bioscience, pharmaceutical, medical device, and dietary supplement industries, Ulmer’s Product Liability Practice Group is a recognized leader that has helped and continues to help set important legal precedent shaping the litigation landscape for those industries.